Relative adrenal insufficiency in the non-critically ill patient with cirrhosis: A systematic review and meta-analysis
- PMID: 36354293
- PMCID: PMC9974795
- DOI: 10.1111/liv.15473
Relative adrenal insufficiency in the non-critically ill patient with cirrhosis: A systematic review and meta-analysis
Abstract
Background & aims: Characterization of relative adrenal insufficiency (RAI) in cirrhosis is heterogeneous with regard to studied patient populations and diagnostic methodology. We aimed to describe the prevalence and prognostic importance of RAI in non-critically ill patients with cirrhosis.
Methods: A systematic review and meta-analysis was performed using MeSH terms and Boolean operators to search five large databases (Ovid-MEDLINE, ScienceDirect, Web of Science, Cochrane Library and ClinicalTrials.gov). The population of interest was patients with cirrhosis and without critical illness. The primary outcome was the pooled prevalence of RAI as defined by a peak total cortisol level <18 μg/dl, delta total cortisol <9 μg/dl or composite of the two thresholds in response either a standard-dose or low-dose short synacthen test. Odds ratios and standardized mean differences from random-effects models estimated important clinical outcomes and patient characteristics by adrenal functional status.
Results: Twenty-two studies were included in final analysis, comprising 1991 patients with cirrhosis. The pooled prevalence of RAI was 37% (95% CI 33-42%). The prevalence of RAI varied by Child-Pugh classification, type of stimulation test used, specific diagnostic threshold and by severity of illness. Ninety-day mortality was significantly higher in patients with RAI (OR 2.88, 95% CI 1.69-4.92, I2 = 15%, p < 0.001).
Conclusions: Relative adrenal insufficiency is highly prevalent in non-critically ill patients with cirrhosis and associated with increased mortality. Despite the proposed multifactorial pathogenesis, no studies to date have investigated therapeutic interventions in this specific population.
Keywords: adrenal insufficiency; cirrhosis; liver; meta-analysis; outcomes research.
© 2022 The Authors. Liver International published by John Wiley & Sons Ltd.
Conflict of interest statement
Figures
Comment in
-
Author's reply: Plasma corticosteroid-binding globulin levels in cirrhosis.Liver Int. 2023 Mar;43(3):742-743. doi: 10.1111/liv.15525. Epub 2023 Jan 24. Liver Int. 2023. PMID: 36655408 No abstract available.
-
Plasma corticosteroid-binding globulin concentrations are preserved in mild cirrhosis.Liver Int. 2023 Mar;43(3):740-741. doi: 10.1111/liv.15524. Epub 2023 Jan 31. Liver Int. 2023. PMID: 36689308 No abstract available.
References
-
- Fede G, Spadaro L, Tomaselli T, et al. Adrenocortical dysfunction in liver disease: a systematic review. Hepatology 2012;55(4):1282–91. - PubMed
-
- Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int 2003;23(2):71–7. - PubMed
-
- Fernández J, Escorsell A, Zabalza M, et al. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Hepatology 2006;44(5):1288–95. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
